NewQuest Capital Partners, an Asia-focused secondaries specialist in which TPG Capital acquired a minority stake last year, has set a target of $850 million for its fourth fund.
The manager has yet to set a hard cap but sources familiar with the situation indicated it would be no more than $1 billion. The firm closed Fund III at $540 million in mid-2016 after raising the hard...
Ascendent Capital Partners has joined Xuan Ruiguo, the chairman and founder of Hong Kong-listed industrial control systems maker China Automation Group, in a take-private offer that values the company at HK$1.5 billion ($197 million).
Australian investment firm Leap Capital has raised A$50 million ($34 million) for a venture debt fund that will target established, revenue-generating companies locally.
Hansoh Pharmaceutical Group, a Chinese drug developer that counts Hillhouse Capital and Boyu Capital among its investors, has raised HK$7.86 billion ($1 billion) through a Hong Kong IPO.
Fidelity International has announced plans to spin-out its proprietary investment arm Eight Roads within the year pending regulatory and shareholder approvals.